197 related articles for article (PubMed ID: 25763797)
1. Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa.
Thienemann F; Dzudie A; Mocumbi AO; Blauwet L; Sani MU; Karaye KM; Ogah OS; Mbanze I; Mbakwem A; Udo P; Tibazarwa K; Ibrahim AS; Burton R; Damasceno A; Stewart S; Sliwa K
BMJ Open; 2014 Oct; 4(10):e005950. PubMed ID: 25763797
[TBL] [Abstract][Full Text] [Related]
2. The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry.
Thienemann F; Dzudie A; Mocumbi AO; Blauwet L; Sani MU; Karaye KM; Ogah OS; Mbanze I; Mbakwem A; Udo P; Tibazarwa K; Damasceno A; Keates AK; Stewart S; Sliwa K
Int J Cardiol; 2016 Oct; 221():205-11. PubMed ID: 27404676
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictive value of electrocardiographic abnormalities in pulmonary hypertension: evidence from the Pan-African Pulmonary Hypertension Cohort (PAPUCO) study.
Balieva I; Dzudie A; Thienemann F; Mocumbi AO; Karaye K; Sani MU; Ogah OS; Voors AA; Kengne AP; Sliwa K
Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):370-376. PubMed ID: 29019518
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in low- and middle-income countries with focus on sub-Saharan Africa.
Dzudie A; Dzekem BS; Ojji DB; Kengne AP; Mocumbi AO; Sliwa K; Thienemann F
Cardiovasc Diagn Ther; 2020 Apr; 10(2):316-324. PubMed ID: 32420114
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-up of Human Immunodeficiency Virus-Associated Pulmonary Hypertension: Clinical Features and Survival Outcomes of the Pan Africa Pulmonary Hypertension Cohort (PAPUCO).
Thienemann F; Katoto PDMC; Azibani F; Kodogo V; Mukasa SL; Sani MU; Karaye KM; Mbanze I; Mocumbi AO; Dzudie A; Sliwa K
Open Forum Infect Dis; 2022 Dec; 9(12):ofac604. PubMed ID: 36601555
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, incidence and aetiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis protocol.
Bigna JJ; Noubiap JJ; Nansseu JR; Aminde LN
BMJ Open; 2017 Jun; 7(6):e014768. PubMed ID: 28624758
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Screening Of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): rationale and design of a multicentre, cross-sectional study.
Cheng Y; Tung CK; Chung AKK; Liu WW; Huang D; Chan PH; Lam M; Chan WC; Siu CW; Hai JJ
BMJ Open; 2019 Aug; 9(8):e027193. PubMed ID: 31375608
[TBL] [Abstract][Full Text] [Related]
9. Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults.
Tsujimoto Y; Kumasawa J; Shimizu S; Nakano Y; Kataoka Y; Tsujimoto H; Kono M; Okabayashi S; Imura H; Mizuta T
Cochrane Database Syst Rev; 2022 May; 5(5):CD012809. PubMed ID: 35532166
[TBL] [Abstract][Full Text] [Related]
10. Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
Lammers AE; Apitz C; Zartner P; Hager A; Dubowy KO; Hansmann G
Heart; 2016 May; 102 Suppl 2():ii1-13. PubMed ID: 27053692
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and incidence of pulmonary hypertension among HIV-infected people in Africa: a systematic review and meta-analysis.
Bigna JJ; Nansseu JR; Um LN; Noumegni SR; Simé PS; Aminde LN; Koulla-Shiro S; Noubiap JJ
BMJ Open; 2016 Aug; 6(8):e011921. PubMed ID: 27554104
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology.
Sliwa K; van Hagen IM; Budts W; Swan L; Sinagra G; Caruana M; Blanco MV; Wagenaar LJ; Johnson MR; Webb G; Hall R; Roos-Hesselink JW;
Eur J Heart Fail; 2016 Sep; 18(9):1119-28. PubMed ID: 27384461
[TBL] [Abstract][Full Text] [Related]
13. A review of pediatric pulmonary hypertension with new guidelines.
Kula S; Pektaş A
Turk J Med Sci; 2017 Apr; 47(2):375-380. PubMed ID: 28425226
[TBL] [Abstract][Full Text] [Related]
14. Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.
Amsallem M; Boulate D; Kooreman Z; Zamanian RT; Fadel G; Schnittger I; Fadel E; McConnell MV; Dhillon G; Mercier O; Haddad F
Int J Cardiovasc Imaging; 2017 Jun; 33(6):825-835. PubMed ID: 28120156
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.
Gerges M; Gerges C; Pistritto AM; Lang MB; Trip P; Jakowitsch J; Binder T; Lang IM
Am J Respir Crit Care Med; 2015 Nov; 192(10):1234-46. PubMed ID: 26181215
[TBL] [Abstract][Full Text] [Related]
16. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Galiè N; Humbert M; Vachiery JL; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Vonk Noordegraaf A; Beghetti M; Ghofrani A; Gomez Sanchez MA; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M;
Eur Heart J; 2016 Jan; 37(1):67-119. PubMed ID: 26320113
[No Abstract] [Full Text] [Related]
17. Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19.
Willder JM; McCall P; Messow CM; Gillies M; Berry C; Shelley B
BMJ Open; 2021 Jan; 11(1):e042098. PubMed ID: 33441361
[TBL] [Abstract][Full Text] [Related]
18. Diuretic versus placebo in normotensive acute pulmonary embolism with right ventricular enlargement and injury: a double-blind randomised placebo controlled study. Protocol of the DiPER study.
Gallet R; Meyer G; Ternacle J; Biendel C; Brunet A; Meneveau N; Rosario R; Couturaud F; Sebbane M; Lamblin N; Bouvaist H; Coste P; Maitre B; Bastuji-Garin S; Dubois-Rande JL; Lim P
BMJ Open; 2015 May; 5(5):e007466. PubMed ID: 26002690
[TBL] [Abstract][Full Text] [Related]
19. HIV status and survival of patients with pulmonary hypertension due to left heart disease: the Pan African Pulmonary Hypertension Cohort.
Katoto PDMC; Mukasa SL; Sani MU; Karaye KM; Mbanze I; Damasceno A; Mocumbi AO; Dzudie A; Sliwa K; Thienemann F
Sci Rep; 2023 Jun; 13(1):9790. PubMed ID: 37328533
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature.
Gunnarsson R; Andreassen AK; Molberg Ø; Lexberg ÅS; Time K; Dhainaut AS; Bertelsen LT; Palm Ø; Irgens K; Becker-Merok A; Nordeide JL; Johnsen V; Pedersen S; Prøven A; Garabet LS; Garen T; Aaløkken TM; Gilboe IM; Gran JT
Rheumatology (Oxford); 2013 Jul; 52(7):1208-13. PubMed ID: 23407386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
